Spire Healthcare Group PLC (LON:SPI)‘s stock had its “hold” rating reissued by analysts at Liberum Capital in a research report issued on Thursday. They currently have a GBX 350 ($4.52) price target on the stock. Liberum Capital’s target price would indicate a potential upside of 34.51% from the company’s current price.

A number of other analysts have also weighed in on SPI. Jefferies Group LLC increased their target price on shares of Spire Healthcare Group PLC from GBX 305 ($3.94) to GBX 350 ($4.52) and gave the stock a “hold” rating in a report on Thursday, June 1st. Berenberg Bank increased their target price on shares of Spire Healthcare Group PLC from GBX 360 ($4.65) to GBX 390 ($5.04) and gave the stock a “buy” rating in a report on Wednesday, June 21st. Credit Suisse Group reiterated an “underperform” rating on shares of Spire Healthcare Group PLC in a report on Friday, July 21st. Finally, Numis Securities Ltd reiterated an “add” rating and set a GBX 375 ($4.84) target price on shares of Spire Healthcare Group PLC in a report on Wednesday, July 26th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of GBX 347 ($4.48).

Spire Healthcare Group PLC (SPI) opened at 260.20 on Thursday. The firm’s market capitalization is GBX 1.04 billion. The stock has a 50 day moving average price of GBX 327.79 and a 200-day moving average price of GBX 332.90. Spire Healthcare Group PLC has a 52 week low of GBX 228.48 and a 52 week high of GBX 411.00.

Spire Healthcare Group PLC (LON:SPI) last announced its quarterly earnings data on Thursday, September 14th. The company reported GBX 8.70 ($0.11) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). The firm had revenue of £481 million for the quarter. Spire Healthcare Group PLC had a return on equity of 3.47% and a net margin of 3.92%. Analysts anticipate that Spire Healthcare Group PLC will post $18.48 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Spire Healthcare Group PLC’s (SPI) Hold Rating Reiterated at Liberum Capital” was published by American Banking News and is owned by of American Banking News. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/09/17/spire-healthcare-group-plcs-spi-hold-rating-reiterated-at-liberum-capital.html.

Spire Healthcare Group PLC Company Profile

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Analyst Recommendations for Spire Healthcare Group PLC (LON:SPI)

Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.